Marinus Pharmaceuticals

Marinus Pharmaceuticals is a pharmaceutical company known for developing ganaxolone (brand name ZTALMY), a neuroactive steroid and GABA-A receptor modulator approved for the treatment of seizures associated with CDKL5 deficiency disorder (CDD). The company operated in the rare-disease and epilepsy space of the life-sciences industry. As of 2026 its corporate domain (marinuspharma.com) redirects to Immedica Pharma (immedicaus.com), reflecting the acquisition of Marinus and its ganaxolone franchise. Marinus was surfaced in the API Evangelist network as a portfolio company of Canaan Partners. As a clinical- and commercial-stage pharmaceutical company it does not publish a public developer API, SDKs, or machine-readable API surface; this profile therefore captures corporate identity and domain security signals only.

Marinus Pharmaceuticals is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Life Sciences, Biotechnology, and Healthcare.

🌐 Visit website 📡 Source on GitHub
7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyPharmaceuticalsLife SciencesBiotechnologyHealthcareRare DiseaseEpilepsyNeurology

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/marinus-pharmaceuticals: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Marinus Pharmaceuticals Domain Security

DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 1

The organization behind the API

Website
Website

Other 1

Properties that don't map to a standard resource type

Company
Company

Source (apis.yml)

apis.yml Raw ↑ 
aid: marinus-pharmaceuticals
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/marinus-pharmaceuticals.png
name: Marinus Pharmaceuticals
description: Marinus Pharmaceuticals is a pharmaceutical company known for developing ganaxolone (brand name ZTALMY), a neuroactive
  steroid and GABA-A receptor modulator approved for the treatment of seizures associated with CDKL5 deficiency disorder (CDD).
  The company operated in the rare-disease and epilepsy space of the life-sciences industry. As of 2026 its corporate domain
  (marinuspharma.com) redirects to Immedica Pharma (immedicaus.com), reflecting the acquisition of Marinus and its ganaxolone
  franchise. Marinus was surfaced in the API Evangelist network as a portfolio company of Canaan Partners. As a clinical-
  and commercial-stage pharmaceutical company it does not publish a public developer API, SDKs, or machine-readable API surface;
  this profile therefore captures corporate identity and domain security signals only.
url: https://raw.githubusercontent.com/api-evangelist/marinus-pharmaceuticals/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Pharmaceuticals
- Life Sciences
- Biotechnology
- Healthcare
- Rare Disease
- Epilepsy
- Neurology
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.marinuspharma.com
- type: Company
  url: https://www.immedicaus.com/en
- type: DomainSecurity
  url: security/marinus-pharmaceuticals-domain-security.yml
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1